Andon Health Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000Q84
CNY
42.04
0.59 (1.42%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
304.05
258.27
507.00
500.14
741.15
588.62
762.30
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
304.05
258.27
507.00
500.14
741.15
588.62
762.30
Raw Material Cost
111.18
120.17
160.90
181.04
203.50
195.76
226.42
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
33.13
35.55
18.97
19.25
16.99
19.80
11.12
Selling and Distribution Expenses
193.11
250.47
230.44
230.31
232.81
178.08
189.47
Other Expenses
2.44
3.94
6.61
6.11
3.94
4.22
3.96
Total Expenditure (Excl Depreciation)
361.87
445.63
476.38
491.70
492.72
435.86
466.60
Operating Profit (PBDIT) excl Other Income
-57.800000000000004
-187.39999999999998
30.6
8.4
248.4
152.79999999999998
295.7
Other Income
192.20
233.73
237.07
203.38
218.19
187.64
179.95
Operating Profit (PBDIT)
130.65
55.63
286.44
176.13
479.51
352.43
494.44
Interest
33.13
35.55
18.97
19.25
16.99
19.80
11.12
Exceptional Items
517.75
677.52
56.09
146.18
525.75
181.25
-113.56
Gross Profit (PBDT)
192.86
138.09
346.10
319.09
537.65
392.86
535.88
Depreciation
0.00
20.06
20.06
13.32
13.32
20.72
20.72
Profit Before Tax
615.26
677.54
303.50
289.74
974.95
493.15
349.04
Tax
-52.32
35.18
25.69
23.27
142.39
102.61
38.56
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
668.89
653.89
266.28
300.09
766.88
354.33
247.43
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
668.89
653.89
266.28
300.09
766.88
354.33
247.43
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.31
-11.53
11.53
-33.62
65.67
36.21
63.05
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
667.58
642.36
277.82
266.47
832.56
390.54
310.48
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
22,189.23
21,774.41
21,421.90
20,736.50
19,272.90
18,764.15
18,741.41
Earnings per share (EPS)
1.63
1.5
0.6
0.68
1.79
0.81
0.55
Diluted Earnings per share
1.63
1.5
0.6
0.68
1.79
0.81
0.55
Operating Profit Margin (Excl OI)
-20.24%
-76.73%
5.78%
-8.11%
33.46%
24.47%
38.54%
Gross Profit Margin
202.36%
270.11%
63.82%
60.6%
133.34%
87.3%
48.51%
PAT Margin
220.0%
253.18%
52.52%
60.0%
103.47%
60.2%
32.46%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 17.69% vs -49.05% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 3.92% vs 131.25% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 65.41% vs -460.53% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is -7.02% vs 87.37% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Andon Health Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
304.05
0
304.05
Other Operating Income
0.00
0.00
0.00
Total Operating income
304.05
0
304.05
Raw Material Cost
111.18
0
111.18
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
33.13
0
33.13
Selling and Distribution Expenses
193.11
0
193.11
Other Expenses
2.44
0.00
2.44
Total Expenditure (Excl Depreciation)
361.87
0
361.87
Operating Profit (PBDIT) excl Other Income
-57.82
0.00
-57.82
Other Income
192.20
0
192.20
Operating Profit (PBDIT)
130.65
0
130.65
Interest
33.13
0
33.13
Exceptional Items
517.75
0
517.75
Gross Profit (PBDT)
192.86
0
192.86
Depreciation
0.00
0
0.00
Profit Before Tax
615.26
0
615.26
Tax
-52.32
0
-52.32
Provisions and contingencies
0
0
0.00
Profit After Tax
668.89
0
668.89
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
668.89
0
668.89
Share in Profit of Associates
0
0
0.00
Minority Interest
-1.31
0
-1.31
Other related items
0.00
0.00
0.00
Consolidated Net Profit
667.58
0
667.58
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
22,189.23
0
22,189.23
Earnings per share (EPS)
1.63
0
1.63
Diluted Earnings per share
1.63
0
1.63
Operating Profit Margin (Excl OI)
-20.24%
0%
0.00
-20.24%
Gross Profit Margin
202.36%
0%
0.00
202.36%
PAT Margin
220.00%
0%
0.00
220.00%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 30.40 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 17.69% vs -49.05% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -58.98% vs 60.31% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 66.76 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 3.92% vs 131.25% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -19.82% vs 2,842.05% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -6.16 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 65.41% vs -460.53% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -123.57% vs 41.24% in Sep 2024

Quarterly - Interest
Interest 3.31 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -7.02% vs 87.37% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 94.71% vs 44.07% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -20.24%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024